Teachers Retirement System of The State of Kentucky Sells 4,057 Shares of CVS Health Co. (NYSE:CVS)

Teachers Retirement System of The State of Kentucky lowered its position in shares of CVS Health Co. (NYSE:CVSGet Rating) by 4.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 93,213 shares of the pharmacy operator’s stock after selling 4,057 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in CVS Health were worth $9,434,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of CVS Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 111,865,662 shares of the pharmacy operator’s stock worth $11,321,923,000 after purchasing an additional 2,628,740 shares during the period. State Street Corp increased its stake in CVS Health by 4.3% during the 1st quarter. State Street Corp now owns 59,261,304 shares of the pharmacy operator’s stock worth $5,997,837,000 after acquiring an additional 2,450,990 shares during the period. Capital World Investors increased its stake in CVS Health by 17.0% during the 1st quarter. Capital World Investors now owns 58,633,421 shares of the pharmacy operator’s stock worth $5,934,465,000 after acquiring an additional 8,531,311 shares during the period. Capital International Investors increased its stake in CVS Health by 1.1% during the 1st quarter. Capital International Investors now owns 28,139,498 shares of the pharmacy operator’s stock worth $2,848,157,000 after acquiring an additional 318,021 shares during the period. Finally, Geode Capital Management LLC increased its stake in CVS Health by 1.9% during the 4th quarter. Geode Capital Management LLC now owns 22,099,200 shares of the pharmacy operator’s stock worth $2,273,690,000 after acquiring an additional 408,181 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Transactions at CVS Health

In other news, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Thomas M. Moriarty sold 138,654 shares of the business’s stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the completion of the sale, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at $59,495,935. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent research reports. Tigress Financial raised their price objective on CVS Health from $125.00 to $130.00 in a research note on Wednesday, August 17th. Mizuho raised their price objective on CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, August 15th. Deutsche Bank Aktiengesellschaft raised their price objective on CVS Health from $113.00 to $120.00 in a research note on Thursday, August 4th. Evercore ISI raised their target price on CVS Health from $120.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, September 7th. Finally, UBS Group raised their target price on CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $117.59.

CVS Health Stock Down 0.2 %

Shares of CVS opened at $102.06 on Friday. The company has a market capitalization of $133.99 billion, a PE ratio of 16.60, a PEG ratio of 1.54 and a beta of 0.73. CVS Health Co. has a 12 month low of $81.78 and a 12 month high of $111.25. The stock’s 50-day moving average price is $99.44 and its two-hundred day moving average price is $99.39. The company has a current ratio of 0.91, a quick ratio of 0.65 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVSGet Rating) last announced its earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, topping the consensus estimate of $2.16 by $0.24. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The firm had revenue of $80.64 billion for the quarter, compared to the consensus estimate of $76.38 billion. During the same period in the previous year, the business earned $2.42 EPS. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. On average, analysts anticipate that CVS Health Co. will post 8.53 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Friday, July 22nd were given a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 2.16%. The ex-dividend date was Thursday, July 21st. CVS Health’s dividend payout ratio (DPR) is presently 35.77%.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Further Reading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.